During the past decade, Georgia Urology conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Georgia Urology" are "Cystitis, Interstitial" (1 trials) and "Prostate Cancer" (1 trials). Many other conditions were trialed in "Georgia Urology" in a lesser frequency.

Most popular intervention types in "Georgia Urology" are "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (1 trials) and "Tanezumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Georgia Urology" are 1 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Georgia Urology". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Georgia Urology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Georgia Urology, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".